Psilocybin From Mushrooms May Reduce Depression Symptoms In People With Cancer

Can psilocybin from mushrooms reduce depression symptoms in people with cancer?Psilocybin-assisted therapy has been studied for treatment-resistant depression and cancer-related psychological distress. In this episode, we examine what current clinical trials show and how this topic is regulated in Europe.In this episode, we cover:• What psilocybin is (a psychedelic compound found in certain mushrooms)• How it may affect serotonin receptors and mood pathways• Research on psilocybin-assisted psychotherapy in cancer patients• Reported effects on depression, anxiety, and end-of-life distress• Safety considerations and psychological screening requirements• Legal status of psilocybin across European countries• Why unsupervised use carries medical and psychiatric risksDoctors assess depression severity, suicide risk, cancer diagnosis, current medications, and psychiatric history before recommending any treatment. Psilocybin therapy remains highly regulated and is generally limited to controlled clinical settings. It is not available as a standard prescription treatment in routine EU telemedicine. Requests for such substances would be declined.This episode reflects how complex mental health conditions are reviewed within structured medical assessment at Mobi Doctor.Read the full medical guide here:https://www.mobidoctor.eu/blog/psilocybin-from-mushrooms-may-reduce-depression-symptoms-in-people-with-cancer